TrialMedical oncology (Northwood, London, England)2013

When less is better: the safety and efficacy of reduced intensity gemcitabine in a difficult patient population with advanced non-small-cell lung cancer.

A Nacci et al.PubMed ↗Publisher ↗

No numbers read from the abstract.